Walleye Trading’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-1,492
Closed -$150K – 4871
2023
Q1
$150K Buy
+1,492
New +$228K ﹤0.01% 3678
2022
Q4
– Sell
-23
Closed -$22K – 5125
2022
Q3
$22K Sell
23
-26
-53% -$25.8K ﹤0.01% 4411
2022
Q2
$33K Buy
+49
New +$30.4K ﹤0.01% 4432
2022
Q1
– Sell
-91
Closed -$82K – 5526
2021
Q4
$82K Buy
+91
New +$86.5K ﹤0.01% 4479
2021
Q2
– Sell
-141
Closed -$104K – 5308
2021
Q1
$104K Buy
+141
New +$114K ﹤0.01% 4071

Other funds holding GOSS

Walleye Trading's GOSS Position: Q2 2023 in Review

Walleye Trading sold out of Gossamer Bio (GOSS) in Q2 2023, closing a stake of 1,492 shares — an estimated $150K sold.

Walleye Trading first reported a position in GOSS in Q1 2021 and held it in 5 quarters. The position peaked at $150K in Q1 2023. 98 funds tracked by Wall St. Rank hold GOSS as of Q2 2023.

  • Walleye Trading reported no remaining Gossamer Bio position as of Q2 2023 after selling out during the quarter.
  • Walleye Trading sold 1,492 Gossamer Bio shares in Q2 2023, an estimated $150K.
  • Walleye Trading first reported a position in Gossamer Bio in Q1 2021 and held it in 5 quarters.
  • Walleye Trading's Gossamer Bio position peaked at $150K in Q1 2023.
  • 98 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2023.

Based on Walleye Trading's 13F filing for Q2 2023, filed 14 Aug 2023.